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Abstract
Background: Fast post-implantation stent endothelialization is desirable for theoretically reducing the possibility of 
stent thrombosis.
Objective: To evaluate the extent of sirolimus-eluting stent strut endothelialization (delivered from the luminal and 
abluminal aspects or abluminal aspect only) in the iliac arteries of rabbits. 
Methods: The iliac arteries of 10 rabbits were implanted with four sirolimus-eluting stents in the luminal and abluminal 
aspects, three sirolimus-eluting stents in the abluminal aspect, six polymer-coated stents, and four uncoated stents. 
After four weeks, the rabbits were euthanized and scanning electron microscopy was performed to quantify the area of 
exposed stent strut as well as the percentage of endothelialization.
Results: The area (mean ± SD) (mm2) of exposed uncoated stent struts, polymer-coated stents, sirulimus-eluting stent 
in the abluminal and luminal aspects and sirolimus-eluting stent in the abluminal aspect was 0.12 ± 0.08, 0.09 ± 
0.12, 0.60 ± 0.67 and 0.05 ± 0.04, respectively (p = 0.120). The percentage of endothelialization (mean ± SD) (%) of 
uncoated stents, polymer-coated stents, sirolimus-eluting stents in the luminal and abluminal aspects and sirolimus-
eluting stents in the abluminal aspect was 99 ± 01, 99 ± 0. 97 ± 03 and 99 ± 0, respectively (p = 0.133).
Conclusion:After four weeks of implantation in the iliac arteries of rabbits, both the sirolimus-eluting stents in the 
luminal plus abluminal aspects and those in the abluminal aspect only showed stent strut endothelialization rates 
similar to those of the other types of non-drug eluting stents. (Arq Bras Cardiol 2012;99(6):1123-1128)
Keywords: Drug eluting stents; arteries; sirolimus; microscopy, electron, scanning.
conceived and developed in Brazil and has recently obtained 
approval from the National Health Surveillance Agency (Agência 
Nacional de Vigilância Sanitária – Anvisa) for clinical use. Sirolimus 
is exclusively delivered from the abluminal surface, i.e., from the 
stent aspect facing the vessel wall, of biodegradable polymers 
and in pre-clinical studies with implantation of a previous 
version of this drug-eluting stent, with sirolimus being delivered 
from both the luminal (stent aspect facing the vessel lumen) and 
the abluminal stent aspect in the coronary arteries of pigs. This 
showed effective inhibition of neointimal proliferation5.
 The presence of sirolimus only in abluminal stent aspect is 
theoretically more advantageous in relation to sirolimus-eluting 
stents in the luminal and abluminal aspects for promoting faster 
stent endothelialization6. 
The presence of bare-metal stent struts uncovered by 
endothelium is known to possibly have an important role in 
predisposition to the occurrence of late thrombosis7-10. Therefore, 
in order to estimate the clinical safety of drug-eluting stents, it is 
important to estimate, in pre-clinical studies, the magnitude of 
stent endothelialization rates after their implantation7,8.
The objective of the present study was to evaluate Scitech® 
sirolimus-eluting stent strut endothelialization (with sirolimus 
Introduction 
Studies in laboratory animals are fundamental for a better 
understanding of the pathophysiology of cardiovascular diseases1. 
These essays enable the development of new diagnostic and 
therapeutic methods, in addition to the evaluation of the safety 
and efficacy of these methods before they are applied in humans2.
The introduction of coronary stents in the therapeutic 
armamentarium of interventional cardiology has resulted 
in remarkable advance in the treatment of coronary artery 
disease, especially after antiproliferative drugs have been 
added to these stents3. 
The Inspiron® sirolimus-eluting stent (Scitech® Medical 
Products, Goiânia, Brazil) is based on a fine-strut chromium-
cobalt (Cro-co) metallic-bond stent (Cronus® stent)4. It was 
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delivered from the luminal and abluminal aspects or abluminal 
aspect only) in the iliac arteries of rabbits by means of scanning 
electron microscopy in comparison to non-drug eluting stent 
endothelialization. 
Methods
All procedures were in accordance with the guidelines of 
protection and care of research animals established in the 
Ethical Principles in Animal Research of the Service of Support 
to Animal Research of Instituto do Coração da Faculdade de 
Medicina da Universidade de São Paulo (HCFMUSP), as well as 
in the Guide for the Care and Use of Laboratory Animals of the 
Institute of Laboratory Animal Resources, Commission on Life 
Sciences and National Research Council, National Academy 
Press (Washington, D.C., 1996) and in the Ethical Principles in 
Animal Research of the Brazilian College of Animal Research 
(Colégio Brasileiro de Experimentação Animal – COBEA). This 
study was approved by the Research Ethics Commission under 
number SDC 2929/07/004.
Angiography
Ten adult male New Zealand non-atherosclerotic rabbits 
with mean weight of 3345 g (2860g to 3897 g) from the 
vivarium of Faculdade de Medicina da Universidade de São 
Paulo (FMUSP) received pre-anesthetic medication with 
intramuscular Ketamine hydrochloride (Ketalar®, Cristália) and 
xylazine hydrochloride 2% (Rompun®, Bayer), and anesthetic 
medication with intravenous sodium pentobarbital (Nembutal®). 
The animals received inhaled oxygen 3 l/min and their 
arterial rate and oxygen saturation was determined by a pulse 
oximeter whose sensor was placed in their tails. 
The right carotid artery of each animal was dissected, and a 
4F vascular sheath was inserted within the artery under direct 
view. Through this sheath, unfractionated heparin 250 IU/kg 
was administered, and a 0.035” hydrophilic wire was directed 
toward the descending aorta under fluoroscopic guidance by 
means of Phillips BV Pulsera® digital angiography equipment. 
A 4F-angiography catheter was then advanced up to the 
distal aorta. Nitroglycerin 200 µg was infused, followed by 
angiographic imaging of the distal descending aorta and iliac 
arteries. A 0.014” Choice® PT guidewire (Boston Scientific 
Corporation) was then introduced through the lumen of the 
angiography catheter up to one of the iliac arteries. After 
removal of the catheter, a 2.5x14-mm pre-mounted stent was 
introduced over the guide and deployed in the iliac artery by 
inflating for 10 seconds at a mean pressure of 7 ATM, with a 
targeted balloon/artery ratio of 1.2:1. The operator was blinded 
to the type of stent implanted in the iliac arteries (right and left) 
of each animal. 
A total of 20 stents (Innovatech Medical Ltda, São Paulo and 
Scitech® Medical Products, Goiânia, Brazil) were implanted, 
of which four were uncovered Cro-Co stens, six were 
polymer-covered Cro-Co stents in the luminal and abluminal 
aspects, three were polymer-covered Cro-Co stents only in 
the abluminal aspect, four were sirolimus-eluting stents in the 
luminal and abluminal aspects, and three were sirolimus-eluting 
stents in the abluminal aspect only. After implantation, the 
vascular sheath was removed, the carotid artery was ligated, and 
prophylactic antibiotic therapy with intramuscular gentamicin 
and benzylpenicillin solution was administered.  
The animal was then sent back to the vivarium and kept for 
four weeks under standard diet and ad libitum water. It would 
later be restudied by means of dissection of the left carotid 
artery and control angiography. 
Euthanasia
The animal was euthanized after control angiography 
by means of an overdose of the anesthetic agent sodium 
pentobarbital, soon after heparinization at a dose of 250 IU/kg. 
Median laparotomy was then performed with exposure of the 
abdominal aorta and inferior vena cava; saline solution 0.9% 
was infused in situ via catheter through the abdominal aorta 
until the content of the sectioned inferior vena cava was a 
clear solution. Next, a modified Karnovsky’s fixative solution 
containing paraformaldehyde 2.0% and glutaraldehyde 2.5% 
in sodium cacodylate buffer solution 0.1 M and pH = 7.4 was 
infused at 100 mmHg pressure for 30 minutes9.
Scanning electron microscopy
The iliac artery segment containing the stent was dissected, 
removed and bisected longitudinally; one of the halves was 
sent to pathological study and the other to specific processing 
and further analysis on a scanning electron microscope. 
The half-segment containing the stent was immersed into 
modified Karnovsky’s solution for 12 hours at 4°C, washed 
in sodium cacodylate buffer solution, post-fixed in osmium 
tetraoxide 1% buffer solution and dehidrated in titrated 
alcohol up to absolute alcohol. The specimens were dried to 
the critical point in a Balzers CPD 030 device, then metalized 
with gold ions in a Balzers SCD 040 device, and analyzed 
in a JSM 7401S (JEOL, Japan) scanning electron microscope 
with 25x magnification. The images obtained were filed and 
analyzed by means of the Adobe® Photoshop® version 7.0 
(Adobe Systems Inc.) and ImageJ version 1.42q for Windows 
(NIH, Bethesda, USA) software programs; the areas of exposed 
stent strut were measured (mm2), and the percentages of 
endothelialization (%) for each type of stent were calculated.
Statistical analysis
Data are described as means ± SD or numbers (percentages). 
Comparison of the means between the types of stents was 
made using one-way analysis of variance (One-way ANOVA). 
If the variance ratio test (F test) were significant, the post-hoc 
analysis of the difference of the means between the groups 
would be made using the Dunnett’s test. The significance 
level was set at 5% (α). The IBM® SPSS® Statistics version 
20 statistical program was used for data analysis.
Results
All 10 rabbits initially survived the procedure of stent 
implantation, and none of them developed any neurological 
deficit as a result of the carotid artery ligation.
Four weeks after stent implantation, nine rabbits/18 stents 
underwent control angiography. One animal (rabbit 8), in 
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which two polymer-coated stents only in the abluminal aspect 
had been implanted, was found dead (undetermined cause of 
death) in the 3rd week post stent implantation. This resulted in 
an insufficient sample size for the analysis of endothelialization 
of polymer-coated stents only in the abluminal aspect, and 
data regarding the other stent of the same type (polymer-
coated stent only in the abluminal aspect) implanted in the 
left iliac artery of rabbit 7 were excluded (Table 1). 
Control angiography
All stents were patent and without angiographic restenosis 
or image suggestive of thrombus at the moment of the restudy 
after four weeks of stent implantation. 
Scanning electron microscopy
The areas analyzed (mean ± SD) measured 17.03 ± 4.82; 
15.89 ± 3.90; 17.97 ± 3.25 and 10.40 ± 4.54 regarding 
the uncoated stent, polymer-coated stent in the luminal and 
abluminal aspects, sirolimus-eluting stent in luminal and 
abluminal aspects and sirolimus-eluting stent in the abluminal 
aspect only, respectively (p = 0.219). 
The areas of stent strut exposed (mean ± SD) (mm2) were 
0.12 ± 0.08; 0.09 ± 0.12; 0.60 ± 0.67 and 0.05 ± 0.04 
(uncoated stent, polymer-coated stent in the luminal and 
abluminal aspects, sirolimus-eluting stent in luminal and 
abluminal aspects and sirolimus-eluting stent in the abluminal 
aspect only, respectively) (p = 0.120).  
Percentages of endothelialization were 99%; 99%; 97% 
and 99% (uncoated stent, polymer-coated stent in the luminal 
and abluminal aspects, sirolimus-eluting stent in luminal and 
abluminal aspects and sirolimus-eluting stent in the abluminal 
aspect only, respectively) (p = 0.133) (Table 2 and Figure 1).
Discussion
The results of this study showed that sirolimus-eluting 
stents in the luminal and abluminal aspects and exclusively in 
Table 1 – Data on the stent implantation procedure and post-operative course
Animal Weight(g) Site of implantation Type of stent implanted Course
1 3767
Right iliac art. Polymer-coated stent in the luminal and abluminal aspects
-
Left iliac art. Sirolimus-eluting stent in the luminal and abluminal aspects
2 3525
Right iliac art. Sirolimus-eluting stent in the luminal and abluminal aspects
-
Left iliac art. Uncoated Cro-Co stent
3 3187
Right iliac art. Polymer-coated stent in the luminal and abluminal aspects
-
Left iliac art. Sirolimus-eluting stent in the luminal and abluminal aspects
4 3897
Right iliac art. Sirolimus-eluting stent in the luminal and abluminal aspects
-
Left iliac art. Uncoated Cro-Co stent 
5 3445
Right iliac art. Uncoated Cro-Co stent
-
Left iliac art. Polymer-coated stent in the luminal and abluminal aspects
6 3410
Right iliac art. Polymer-coated stent in the luminal and abluminal aspects
-
Left iliac art. Uncoated Cro-Co stent 
7 3224
Right iliac art. Sirolimus-eluting stent in the abluminal aspect only -
Left iliac art. Polymer-coated stent in the abluminal aspect Data on this stent were excluded from the  final analysis
8 2860
Right iliac art. Polymer-coated stent in the abluminal aspect 
Death on the 3rd  post-
implantation weekLeft iliac art. Polymer-coated stent in the abluminal aspect 
9 3095
Right iliac art. Polymer-coated stent in the luminal and abluminal aspects
-
Left iliac art. Sirolimus-eluting stent in the abluminal aspect only 
10 3042
Right iliac art. Sirolimus-eluting stent in the abluminal aspect only 
-
Left iliac art. Polymer-coated stent in the luminal and abluminal aspects
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Table 2 – Quantification of endothelialization after stent implantation in iliac arteries of rabbits as assessed by scanning electron microscopy
Uncoated 
Cro-Co stent 
(n = 4)
Polymer-coated Cro-Co 
stent in the luminal and 
abluminal aspects
(n = 6)
Sirolimus-eluting stent 
in the luminal and 
abluminal aspects
(n = 4)
Sirolimus-eluting stent 
in the abluminal aspect 
(n = 3)
p value
Area analyzed (mm2) 17.03 ± 4.82 15.89 ± 3.90 17.97 ± 3.25 10.40 ± 4.54 0.219
Area of exposed strut (mm2) 0.12 ± 0.08 0.09 ± 0.12 0.60 ± 0.67 0.05 ± 0.04 0.120
Percentage area of exposed strut (%) 0.8 ± 0.7 0.5 ± 0 3.0 ± 3.2 0.4 ± 0.3 0.192
Percentage endothelialization (%) 99 ± 01 99 ± 0 97 ± 03 99 ± 0 0.133
abluminal aspect  had a rate of stent-strut endothelialization 
similar to that found in non-eluting stents after four weeks of 
implantation in the iliac arteries of non-atherosclerotic rabbits. 
Several coronary stents eluted in antiproliferative drugs 
showed effective inhibition of neointimal proliferation and 
reduction of restenosis rates, as well as  the need for target-vessel 
reintervention. One of the concerns related to the use of these 
drug stents is the probability, albeit rare, of the occurrence of 
late thrombosis8. Fast post-implantation endothelialization of 
drug stents is a desirable phenomenon for theoretically reducing 
the risk of both early and late thrombosis10.
P re - c l in i ca l  eva lua t ion  o f  pos t - imp lan ta t ion 
reendothelialization of drug stents is preferably made by 
implanting these stents in the iliac arteries of rabbits, since 
the results obtained with these animals are the ones that are 
most similar to those observed in humans11. The coronary 
arteries of pigs reendothelialize very quickly after stent 
implantation and are more useful for the assessment of 
implant safety. Additionally, pre-clinical studies with stent 
implantation in animals with induced atherosclerosis are 
currently recommended12,13. 
When endothelialization data from Inspiron® sirolimus-
eluting stents (Scitech®, Goiânia, Brazil) are compared to the 
experimental data from Joner et al’s study14 as regards stent 
strut endothelialization, we verify that the Inspiron® stent 
endothelialization rate (99%) is higher than that of other 
drug stents (Cypher®: 64%, Taxus®: 68%, Endeavor®: 76% 
and Xience V®: 80%) for the same observation period of four 
weeks post-implantation. This difference may result from the 
sirolimus elution only in the abluminal aspect in the Inspiron® 
stent, whereas the antiproliferative drugs are released from 
both stent aspects in the other stents. Another factor that could 
explain this difference is that we did not perform denudation 
prior to the stent implantation, thus minimizing the occurrence 
of arterial spasm, trauma, and arterial dissection. Thus, using 
this methodology, we could only analyze endothelialization 
on the stent struts, but not between the stent struts. Another 
methodological difference of our study in relation to Joner et 
al’s study14 is that we used the carotid approach whereas they 
used the femoral approach. The use of the femoral approach 
with artery ligation at the end of stent implantation in iliac 
arteries may cause the arterial flow to slow down upstream 
from the ligation point, and this would theoretically have 
an impact on several aspects of coagulation and possibly 
on stent endothelialization; for this reason we chose the 
carotid approach15.
Study limitations
Non-atherosclerotic animals were used in the present 
study. However, because of the atherosclerotic process 
specificities (multifactorial, chronic disease), an animal model 
with atherosclerosis reliably reproducing this abnormality as 
seen in humans has not yet been developed. 
The observation period post-stent implantation in iliac 
arteries of rabbits was 30 days. We observed low standard-
deviations (minimum of 0 and maximum of 0.03) for the rates 
of endothelialization on the stent struts studied; thus,  by using 
a test power of 80% and admitting a beta error of 5%, we 
calculated that the sample number for each type of stent was 
sufficient, except for the group of polymer-coated stents in the 
abluminal aspect, which was removed from this comparative 
analysis. However, groups of additional animals could have 
been studied for shorter observation periods (seven and/or 
14 days), but this was not the object of this initial investigation. 
The functional aspects of the neointima recovering the 
stent struts after four weeks of implantation were not assessed 
in the present study.
Figure 1 – Images obtained by scanning electron microscopy of the luminal 
aspect of the iliac arteries of rabbits after four weeks of stent implantation. (A) 
uncoated Cro-Co stent; (B) polymer-coated Cro-Co stent in the luminal and 
abluminal aspects; (C) sirolimus-eluting stent in the luminal and abluminal 
aspects; (D) sirolimus-eluting stent in the abluminal aspect only
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Conclusion
After four weeks of implantation in the iliac arteries of 
rabbits, the drug stents releasing sirolimus from the luminal and 
abluminal aspects and abluminal aspect only showed almost 
complete endothelialization on struts  (97% to 99%) with no 
statistically difference from endothelialization occurring in 
non-drug eluting stents (uncoated stents and polymer-coated 
stents in the luminal and abluminal aspects) (99%).
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